A Dietary Supplement Examined for Anti-ageing Effects
Launched by PRENETICS GLOBAL · Dec 2, 2024
Trial Information
Current as of June 28, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a dietary supplement designed to help with signs of aging. The researchers want to see if this supplement can promote healthy aging in adults. The study is not yet recruiting participants, but they will be looking for healthy adults between the ages of 12 and 25 who do not have any serious diseases that would prevent them from joining.
If you or someone you know fits this age range and is healthy, you might be eligible to participate. Those who join the study can expect to take the dietary supplement and provide feedback on its effects. It's a great opportunity to contribute to research that could benefit many people looking to maintain their health as they age.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Healthy Adults -
- • Exclusion Criteria: Diseases deemed to be unable to participate in the study
- • -
About Prenetics Global
Prenetics Global is a leading biotechnology company specializing in genetic testing and precision medicine. With a commitment to harnessing the power of genomics, Prenetics develops innovative testing solutions that empower individuals and healthcare providers to make informed decisions about health and wellness. The company’s cutting-edge technologies focus on areas such as hereditary disease screening, cancer detection, and pharmacogenomics, enhancing patient outcomes through personalized insights. As a clinical trial sponsor, Prenetics Global is dedicated to advancing research and development in the field of genomics, driving progress in healthcare through rigorous scientific methodologies and a strong emphasis on patient-centric care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported